Nektar: Q4 Earnings Snapshot

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Nektar Therapeutics (NKTR) on Wednesday reported fourth-quarter earnings of $7.3 million.

The San Francisco-based company said it had net income of 3 cents per share. Earnings, adjusted for non-recurring costs, came to 15 cents per share.

The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The biopharmaceutical company posted revenue of $29.2 million in the period, which did not meet Street forecasts. Eight analysts surveyed by Zacks expected $39 million.

For the year, the company reported a loss of $119 million, or 58 cents per share. Revenue was reported as $98.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NKTR at https://www.zacks.com/ap/NKTR

Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up